Technical Analysis for FBIO - Fortress Biotech, Inc.

Grade Last Price % Change Price Change
grade B 1.85 4.52% 0.08
FBIO closed up 4.52 percent on Friday, May 24, 2019, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical FBIO trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
50 DMA Support Bullish 4.52%
Upper Bollinger Band Walk Strength -4.64%
Overbought Stochastic Strength -4.64%
Upper Bollinger Band Walk Strength -4.64%
Overbought Stochastic Strength -4.64%

Older signals for FBIO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Fortress Biotech, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company's principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201, a biologic comprising the microscopic eggs of the porcine whipworm for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, or autism spectrum disorder; and CNDO-109, a biologic that activates the immune system's natural killer cells to seek and destroy cancer cells for the treatment of acute myeloid leukemia. It has strategic alliances and commercial agreements with Ovamed GmbHp; Dr. Falk Pharma GmbH; and Freie Universität Berlin. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was founded in 2006 and is based in Burlington, Massachusetts.
Medicine Biotechnology Biopharmaceutical Cancer Medical Specialties Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Acute Myeloid Leukemia Ulcerative Colitis Abdominal Pain Crohn's Disease Treatment Of Acute Myeloid Leukemia Treatment Of Autoimmune Diseases
Is FBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.6
52 Week Low 0.49
Average Volume 858,721
200-Day Moving Average 1.5528
50-Day Moving Average 1.7648
20-Day Moving Average 1.7485
10-Day Moving Average 1.831
Average True Range 0.1846
ADX 15.26
+DI 21.4581
-DI 17.8553
Chandelier Exit (Long, 3 ATRs ) 1.4862
Chandelier Exit (Short, 3 ATRs ) 1.9138
Upper Bollinger Band 2.0083
Lower Bollinger Band 1.4887
Percent B (%b) 0.7
BandWidth 29.7169
MACD Line 0.0422
MACD Signal Line 0.026
MACD Histogram 0.0161
Fundamentals Value
Market Cap 93.47 Million
Num Shares 50.5 Million
EPS -1.48
Price-to-Earnings (P/E) Ratio -1.25
Price-to-Sales 1.68
Price-to-Book 2.53
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.99
Resistance 3 (R3) 1.98 1.92 1.96
Resistance 2 (R2) 1.92 1.89 1.93 1.95
Resistance 1 (R1) 1.89 1.87 1.91 1.90 1.95
Pivot Point 1.83 1.83 1.84 1.84 1.83
Support 1 (S1) 1.80 1.80 1.82 1.81 1.75
Support 2 (S2) 1.74 1.78 1.75 1.75
Support 3 (S3) 1.71 1.74 1.74
Support 4 (S4) 1.72